Milestone Scientific Inc. (MLSS)
NYSEAMERICAN: MLSS · Real-Time Price · USD
0.3805
-0.0338 (-8.16%)
Nov 6, 2025, 11:24 AM EST - Market open
Milestone Scientific Revenue
Milestone Scientific had revenue of $2.32M in the quarter ending June 30, 2025, with 25.34% growth. This brings the company's revenue in the last twelve months to $9.08M, up 7.84% year-over-year. In the year 2024, Milestone Scientific had annual revenue of $8.63M, down -12.19%.
Revenue (ttm)
$9.08M
Revenue Growth
+7.84%
P/S Ratio
3.67
Revenue / Employee
$534,306
Employees
17
Market Cap
29.89M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.63M | -1.20M | -12.19% |
| Dec 31, 2023 | 9.83M | 1.02M | 11.60% |
| Dec 31, 2022 | 8.81M | -1.50M | -14.54% |
| Dec 31, 2021 | 10.30M | 4.87M | 89.52% |
| Dec 31, 2020 | 5.44M | -2.94M | -35.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
MLSS News
- 23 days ago - Milestone Scientific Highlights Operational Progress and Growth Initiatives Under New Leadership - GlobeNewsWire
- 23 days ago - Milestone Scientific Commits to Regaining NYSE American Compliance Following Notification - GlobeNewsWire
- 6 weeks ago - Milestone Scientific Appoints Dr. Dawood Sayed to Board of Directors to Advance Commercial and Clinical Strategy in Pain Management - GlobeNewsWire
- 2 months ago - Milestone Scientific Achieves 25% Increase in Revenue for the Second Quarter of 2025 - GlobeNewsWire
- 3 months ago - Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call - GlobeNewsWire
- 3 months ago - Milestone Scientific Appoints Jason Papes as Senior Vice President, Global Head of Sales and Marketing - GlobeNewsWire
- 3 months ago - Milestone Scientific Appoints Eric C. Hines as Chief Executive Officer - GlobeNewsWire
- 4 months ago - Milestone Scientific Commences Sales of CompuFlo® Epidural System at The Painless Center in Tenafly, New Jersey - GlobeNewsWire